Rapid Serological Tests for Sars-Cov-2: Diagnostic Performance of Four Commercial Assays

Conclusion. Our data demonstrate the excellent performance of LFA for the diagnoses of definit e or probable SARS-CoV-2 infection. There was substantial heterogeneity in sensitivities of IgM and IgG antibodies among the manufacturers. LFA tests cannot replace molecular diagnostics, but should be used as additional screening tool.
Source: Medical Principles and Practice - Category: Internal Medicine Source Type: research